Fine N Scott
Cyclo Therapeutics, Inc. · Chief Executive Officer
Fine N Scott serves as the Chief Executive Officer of Cyclo Therapeutics, Inc., a firm focused on innovative healthcare solutions. His recent disclosures reflect activity within the company, particularly a significant grant/exercise valued at approximately $340.9K on June 5, 2024. Across two public disclosures, his transactions are exclusively tied to Cyclo Therapeutics, Inc. (CYTHW and CYTH), indicating a concentrated engagement in the healthcare sector.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||